Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-014720
Filing Date
2025-06-11
Accepted
2025-06-11 16:30:39
Documents
15

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 138161
2 EX-5.1 ex5-1.htm EX-5.1 10468
3 EX-23.1 ex23-1.htm EX-23.1 2084
4 EX-FILING FEES ex107.htm   iXBRL EX-FILING FEES 29118
5 GRAPHIC ex5-1_001.jpg GRAPHIC 5580
  Complete submission text file 0001641172-25-014720.txt   316852

Data Files

Seq Description Document Type Size
17 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 7631
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-287954 | Film No.: 251040454
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)